{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T05:36:10Z","timestamp":1771047370905,"version":"3.50.1"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,3]]},"abstract":"<jats:sec>\n            <jats:title>Objective<\/jats:title>\n            <jats:p>The diagnosis of inflammatory bowel disease (IBD) associated with high-grade dysplasia (HGD) has a significant impact on clinical management, including colectomy. However, the prognosis of HGD remains unclear due to diagnostic uncertainty and low-quality data on subsequent synchronous and metachronous neoplasia. We aimed to evaluate a diagnostic strategy with dedicated gastrointestinal (GI) pathologist consensus of revised HGD and the impact on synchronous and metachronous neoplasia rates.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>In this retrospective multicenter cohort study, we used the Dutch Nationwide Pathology Databank to identify IBD patients with HGD in seven hospitals. Histopathological specimens of the initial HGD were independently revised by two dedicated GI pathologists. Definitive diagnosis was established in a consensus meeting. Synchronous and metachronous neoplasia incidences were assessed with a competing risk analysis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>We included 54 IBD patients with HGD, of whom 33 (61.1%) with ulcerative colitis and 42 (77.8%) with extensive disease. After consensus, 18 (33.3%) lesions were downgraded to indefinite\/low-grade dysplasia, and 6 (11.1%) were revised to colorectal cancer (CRC). Seven patients (13.0%) had synchronous CRC. Patients with downgraded lesions showed a lower cumulative advanced neoplasia (HGD\/CRC) incidence compared with confirmed HGD [(Gray\u2019s test <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u20050.01), 5-year cumulative incidence 0.0% vs. 26.6%].<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>We demonstrated frequent downgrading of HGD, associated with lower metachronous neoplasia rates. This underlines the potential impact of dedicated GI pathologist consensus meetings. The high and synchronous and metachronous neoplasia rates after HGD underline the need for close surveillance.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/meg.0000000000002897","type":"journal-article","created":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T18:03:50Z","timestamp":1738951430000},"page":"287-294","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Gastrointestinal pathologist consensus of revised high-grade dysplasia in inflammatory bowel disease impacts the advanced neoplasia rate: a multicenter study"],"prefix":"10.1097","volume":"37","author":[{"given":"Maarten","family":"te Groen","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Inflammatory Bowel Disease Centre"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica E.W.","family":"Derks","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Inflammatory Bowel Disease Centre"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iris D.","family":"Nagtegaal","sequence":"additional","affiliation":[{"name":"Department of Pathology, Radboud University Medical Centre, Nijmegen"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte P.","family":"Peters","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Amsterdam University Medical Centre, location AMC, Amsterdam"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annemarie C.","family":"de Vries","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Erasmus Medical Centre, Rotterdam"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerard","family":"Dijkstra","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Groningen University Medical Centre, Groningen"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tessa E.H.","family":"Romkens","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Jeroen Bosch Hospital, Den Bosch"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen S.","family":"Horjus","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Rijnstate Hospital, Arnhem"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nanne K.","family":"de Boer","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, AGEM Research Institute, Amsterdam University Medical Centre, location Vrije Universiteit Amsterdam, Amsterdam, the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michiel E.","family":"de Jong","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Inflammatory Bowel Disease Centre"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Britt","family":"van Ruijven","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Inflammatory Bowel Disease Centre"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Hoentjen","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Inflammatory Bowel Disease Centre"},{"name":"Division of Gastroenterology, Department of Medicine, University of Alberta, Edmonton, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoko","family":"Vos","sequence":"additional","affiliation":[{"name":"Department of Pathology, Radboud University Medical Centre, Nijmegen"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauranne A.A.P.","family":"Derikx","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Inflammatory Bowel Disease Centre"},{"name":"Department of Gastroenterology, Erasmus Medical Centre, Rotterdam"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"on behalf of the Dutch Initiative on Crohn\u2019s and Colitis (ICC) and the Dutch Nationwide Pathology Databank (PALGA) group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,1,29]]},"reference":[{"key":"R1-20250207","doi-asserted-by":"crossref","first-page":"s1","DOI":"10.1136\/gutjnl-2019-318484","article-title":"British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults.","volume":"68","author":"Lamb","year":"2019","journal-title":"Gut"},{"key":"R2-20250207","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1093\/ecco-jcc\/jjx008","article-title":"Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 1: definitions, diagnosis, extra-intestinal manifestations, pregnancy, cancer surveillance, surgery, and ileo-anal pouch disorders.","volume":"11","author":"Magro","year":"2017","journal-title":"J Crohns Colitis"},{"key":"R3-20250207","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1053\/j.gastro.2021.05.063","article-title":"AGA clinical practice update on endoscopic surveillance and management of colorectal dysplasia in inflammatory bowel diseases: expert review.","volume":"161","author":"Murthy","year":"2021","journal-title":"Gastroenterology"},{"key":"R4-20250207","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0140-6736(94)90813-3","article-title":"Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis?","volume":"343","author":"Bernstein","year":"1994","journal-title":"Lancet"},{"key":"R5-20250207","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1080\/00365520801909686","article-title":"High-grade dysplastic adenoma-like mass lesions are not an indication for colectomy in patients with ulcerative colitis.","volume":"43","author":"Blonski","year":"2008","journal-title":"Scand J Gastroenterol"},{"key":"R6-20250207","doi-asserted-by":"crossref","first-page":"4980","DOI":"10.3748\/wjg.v20.i17.4980","article-title":"Histological healing favors lower risk of colon carcinoma in extensive ulcerative colitis.","volume":"20","author":"Korelitz","year":"2014","journal-title":"World J Gastroenterol"},{"key":"R7-20250207","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/ajg.2015.248","article-title":"Low-grade dysplasia in ulcerative colitis: risk factors for developing high-grade dysplasia or colorectal cancer.","volume":"110","author":"Choi","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"R8-20250207","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/apt.15778","article-title":"Systematic review with meta-analysis: IBD-associated colonic dysplasia prognosis in the videoendoscopic era (1990 to present).","volume":"52","author":"Kabir","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"R9-20250207","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/modpathol.3880534","article-title":"Interobserver variability in the diagnosis of ulcerative colitis-associated dysplasia by telepathology.","volume":"15","author":"Odze","year":"2002","journal-title":"Mod Pathol"},{"key":"R10-20250207","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/path.876","article-title":"Inter-observer variation between general and specialist gastrointestinal pathologists when grading dysplasia in ulcerative colitis.","volume":"194","author":"Eaden","year":"2001","journal-title":"J Pathol"},{"key":"R11-20250207","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s10151-020-02349-9","article-title":"Diagnostic interobserver variability in Crohn\u2019s disease- and ulcerative colitis-associated dysplasia: a multicenter digital survey from the IG-IBD Pathologists Group.","volume":"25","author":"Leoncini","year":"2021","journal-title":"Tech Coloproctol"},{"key":"R12-20250207","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/S0046-8177(83)80175-0","article-title":"Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications.","volume":"14","author":"Riddell","year":"1983","journal-title":"Hum Pathol"},{"key":"R13-20250207","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/den.13387","article-title":"Histopathological diagnosis of ulcerative colitis-associated neoplasia.","volume":"31","author":"Kawachi","year":"2019","journal-title":"Dig Endosc"},{"key":"R14-20250207","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1053\/j.gastro.2015.01.031","article-title":"Scenic international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease.","volume":"148","author":"Laine","year":"2015","journal-title":"Gastroenterology"},{"key":"R15-20250207","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1002\/ibd.21467","article-title":"Misclassification of dysplasia in patients with inflammatory bowel disease: consequences for progression rates to advanced neoplasia.","volume":"17","author":"van Schaik","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"R16-20250207","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1136\/gutjnl-2014-307278","article-title":"Barrett\u2019s oesophagus patients with low-grade dysplasia can be accurately risk-stratified after histological review by an expert pathology panel.","volume":"64","author":"Duits","year":"2015","journal-title":"Gut"},{"key":"R17-20250207","first-page":"A1899","article-title":"[Guideline \u2018Diagnosis and treatment of inflammatory bowel disease in adults\u2019. I. Diagnosis and treatment].","volume":"154","author":"van Bodegraven","year":"2010","journal-title":"Ned Tijdschr Geneeskd"},{"key":"R18-20250207","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1093\/ecco-jcc\/jjz114","article-title":"Long-term risk of advanced neoplasia after colonic low-grade dysplasia in patients with inflammatory bowel disease: a nationwide cohort study.","volume":"13","author":"De Jong","year":"2019","journal-title":"J Crohns Colitis"},{"issue":"19 Suppl A","key":"R19-20250207","doi-asserted-by":"crossref","first-page":"5A","DOI":"10.1155\/2005\/269076","article-title":"Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology.","volume":"19","author":"Silverberg","year":"2005","journal-title":"Can J Gastroenterol"},{"key":"R20-20250207","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S0016-5107(03)02159-X","article-title":"The Paris endoscopic classification of superficial neoplastic lesions: esophagus, stomach, and colon: November 30 to December 1, 2002.","volume":"58","year":"2003","journal-title":"Gastrointest Endosc"},{"key":"R22-20250207","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1161\/CIRCULATIONAHA.115.017719","article-title":"Introduction to the analysis of survival data in the presence of competing risks.","volume":"133","author":"Austin","year":"2016","journal-title":"Circulation"},{"key":"R23-20250207","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1214\/aos\/1176350951","article-title":"A class of K-sample tests for comparing the cumulative incidence of a competing risk.","volume":"16","author":"Gray","year":"1988","journal-title":"Ann Stat"},{"key":"R25-20250207","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1055\/s-2006-944993","article-title":"Frequency of Barrett\u2019s neoplasia after initial negative endoscopy with biopsy: a long-term histopathological follow-up study.","volume":"38","author":"Vieth","year":"2006","journal-title":"Endoscopy"},{"key":"R26-20250207","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/SLA.0b013e31828e7417","article-title":"Risk and location of cancer in patients with preoperative colitis-associated dysplasia undergoing proctocolectomy.","volume":"259","author":"Kiran","year":"2014","journal-title":"Ann Surg"},{"key":"R27-20250207","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1158\/1078-0432.CCR-12-0455","article-title":"Competing risk analyses: how are they different and why should you care?","volume":"18","author":"Chappell","year":"2012","journal-title":"Clin Cancer Res"},{"key":"R28-20250207","doi-asserted-by":"crossref","first-page":"e1001531","DOI":"10.1371\/journal.pmed.1001531","article-title":"Use of expert panels to define the reference standard in diagnostic research: a systematic review of published methods and reporting.","volume":"10","author":"Bertens","year":"2013","journal-title":"PLoS Med"},{"key":"R29-20250207","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0300-2977(00)00086-3","article-title":"Comprehensive Cancer Centre Amsterdam Barrett Advisory Committee: first results.","volume":"58","author":"Hulscher","year":"2001","journal-title":"Neth J Med"},{"key":"R30-20250207","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1136\/jclinpath-2020-206511","article-title":"Performance of gastrointestinal pathologists within a national digital review panel for Barrett\u2019s oesophagus in the Netherlands: results of 80 prospective biopsy reviews.","volume":"74","author":"Klaver","year":"2021","journal-title":"J Clin Pathol"}],"container-title":["European Journal of Gastroenterology &amp; Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MEG.0000000000002897","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T18:04:01Z","timestamp":1738951441000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MEG.0000000000002897"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,29]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/meg.0000000000002897","relation":{},"ISSN":["1473-5687"],"issn-type":[{"value":"1473-5687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,29]]}}}